• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Astec LifeSciences Limited — Board Meeting, 29-10-2025: Outcome of Board Meeting

    29-10-2025 | 05:07 pm

    Astec LifeSciences' board approved Q2 & H1 FY26 financial results. Consolidated revenue for Q2 was ₹73.72 Cr, with a loss of ₹24.42 Cr. Half-year consolidated revenue reached ₹164.80 Cr, with a loss of ₹57.44 Cr.

    No comments yet. Be the first to comment!

    All announcements from Astec LifeSciences Limited